Global Hospital-Acquired Infection Control Market 2017-2021
- Published: Jul 2017
- Pages: 70
- SKU: IRTNTR13353
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
This industry research report identifies AstraZeneca, GlaxoSmithKline, Merck, and Pfizer as the key vendors in the global hospital-acquired infection control market. A comprehensive analysis of this market is also presented by infection type (CAUTIs, SSIs, CLABSIs, and respiratory infections), by end-user (hospitals and ICUs, outpatient care centers, LTCFs, and others), and by geography (the Americas, APAC, and EMEA).
Hospital-acquired infection control market forecasts
Market research analysts at Technavio predict that the global hospital-acquired infection control market will grow steadily at a CAGR of around 5% by 2021. The adoption of data analytics to improve healthcare facilities is identified as one of the primary growth factors for this market. Data analytics refers to the collection of tools and techniques that are used to generate insights and take actions based on real-time data.
Over the years, the healthcare systems have been collecting data through electronic medical records (EMRs) and electronic health records (EHRs). When this data is analyzed using numerous data analytics techniques, it helps reach valuable conclusions and deductions that can be used to improve healthcare settings and even reduce the prevalence of hospital-acquired infection (HAIs). Several information technology companies are employing various algorithms to arrive at inferences that could help improve hospital-acquired infection control. Additionally, government organizations also use data analytics to improve their measures to tackle hospital-acquired infections.
HAI control market growth based on geography
In terms of geographic regions, the Americas will be the major revenue contributor to the hospital-acquired infection control market throughout the forecast period. The increase in hospital-acquired infection research and the launch of new products drive the market’s growth in this region. Moreover, the rise in government initiatives to combat the rising occurrences of hospital-acquired infections will also boost the growth of the hospital-acquired infection control market in this region.
Hospital-acquired infection control market worth: Competitive landscape and key vendors
The hospital-acquired infection control market is quite competitive and consists of leading pharmaceutical companies who account for most of the market shares. Companies with limited experience are developing innovative solutions to control hospital-acquired infections. Investments in the manufacturing to expand production facilities and considerable efforts to develop advanced drugs that can cure hospital-acquired infections are the key strategies employed by the market players. To expand the customer base, some key companies are also focusing on launching products with equitable prices that can be profitable for the company and affordable for the patients.
The leading vendors in the HAI market
- AstraZeneca
- GlaxoSmithKline
- Merck
- Pfizer
Hospital-acquired infection control market segmentation by infection type
- Catheter-associated urinary tract infections (CAUTIs)
- Surgical site infections (SSIs)
- Central line-associated bloodstream infections (CLABSIs)
- Respiratory infections
During 2016, the CAUTIs segment accounted for the major shares of the hospital-acquired infection control market. Factors such as the increase in the number of hospital admissions due to urinary tract infections (UTIs) and the improper maintenance of healthcare facilities, will contribute to the growth of this industry segment in the coming years.
Hospital-acquired infection control market forecast by end-user
- Hospitals and ICUs
- Outpatient care centers
- Long-term care facilities (LTCFs)
As per this market research report, hospitals and ICUs held the maximum market share of the hospital-acquired infection control market during 2016. The prevalence of hospital-acquired infections is high in hospitals and ICUs as they lack adequate maintenance due to the high volume of patients and limited budgets. Moreover, the staff shortage in hospitals and ICUs also increases the prevalence of HAIs as patients do not get the required attention. These factors will drive the growth in demand for hospital-acquired infections control products from hospitals and ICUs during the forecast period.
Want a bigger picture? Try a FREE sample of this report now!
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Key questions answered in the report include
- What will the market size and the growth rate be in 2021?
- What are the key factors driving the global hospital-acquired infection control market?
- What are the key market trends impacting the growth of the global hospital-acquired infection control market?
- What are the challenges to market growth?
- Who are the key vendors in the global hospital-acquired infection control market?
- What are the market opportunities and threats faced by the vendors in the global hospital-acquired infection control market?
- Trending factors influencing the market shares of the Americas, APAC, and EMEA.
- What are the key outcomes of the five forces analysis of the global hospital-acquired infection control market?
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
- Overview
PART 05: Market landscape
- Overview
- Market size and forecast
- Five forces analysis
PART 06: Segmentation by infection type
- Overview
- CAUTIs
- SSIs
- CLABSIs
- Respiratory infections
PART 07: Segmentation by end-user
- Overview
- Hospitals and ICUs
- Outpatient care centers
- LTCFs
- Others
PART 08: Segmentation by geography
- Overview
- Americas
- EMEA
- APAC
PART 09: Decision framework
PART 10: Drivers and challenges
- Market drivers
- Market challenges
PART 11: Market trends
- Emergence of innovative techniques to remove biofilms
- Decrease in regulatory approvals of antibiotics
- Focus on early diagnosis and preventive medicine
- Cost burden of HAIs on patients and hospitals
PART 12: Vendor landscape
- Competitive scenario
PART 13: Key vendor analysis
- AstraZeneca
- GlaxoSmithKline
- Merck
- Pfizer
- Other prominent vendors
PART 14: Appendix
- List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
